-

SHAREHOLDER ALERT: Robbins LLP Announces that Kanzhun Limited (BZ) is Being Sued for Misleading Shareholders

SAN DIEGO & BEIJING--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Kanzhun Limited (NASDAQ: BZ) American Depository Shares ("ADSs") between June 11, 2021 and July 2, 2021, for violations of the Securities Exchange Act of 1934. Kanzhun operates an online recruitment platform, BOSS Zhipin, a mobile-native product that promotes instant direct chats between employers and job seekers, which is powered by proprietary artificial intelligence algorithms and big data insights.

If you suffered a loss due to Kanzhun Limited's misconduct, click here.

Kanzhun Limited (BZ) Misled the Investing Public Regarding Its Cybersecurity Risks

According to the complaint, on July 5, 2021, Kanzhun announced that it was "subject to cybersecurity review by" the Cyberspace Administration of China ("CAC"). During the review period, its BOSS Zhipin app is required to suspend new user registration. On this news, shares of Kanzhun's ADSs fell $5.79, or 15%, to close at $30.52 per ADS on July 6, 2021.

The complaint alleges that the offering documents filed by Kanzhun in support of its June 2021 initial public offering failed to disclose that: (i) Kanzhun would face an imminent cybersecurity review by the "CAC"; (ii) the CAC would require Kanzhun to suspend new user registration of its BOSS Zhipin app; (iii) Kanzhun needed to "conduct a comprehensive examination of cybersecurity risks"; (iv) Kanzhun needed to "enhance its cybersecurity awareness and technology capabilities"; and (v) as a result, defendants' statements about its business, operations, and prospects were materially false and misleading.

If you purchased shares of Kanzhun Limited (BZ) between June 11, 2021 and July 2, 2021, you have until September 10, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Kanzhun Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:BZ
Release Versions
English
$Cashtags
$BZ
Hashtags
#Kanzhun
#LawFirm
#Shareholder
#ShareholderRights
#StockMarket
#StockNews
#Stocks

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. For more information...

VIA Transportation, Inc. Stock Drop: Harmed Investors Should Contact Robbins LLP for Information About Leading the Class Action Against VIA

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Via Transportation, Inc. (NYSE: VIA) in connection with the Company's September 15, 2025 initial public statement ("IPO"). Via Transportation, Inc. provides a platform that transforms global transportation systems into digital networks in the United States, Germany, and internationally.For more information, submit a form, email attorney Aaron D...
Back to Newsroom